Angiogenesis Inhibitors in NSCLC

Angiogenesis is a complex biological process that plays a relevant role in sustaining the microenvironment, growth, and metastatic potential of several tumors, including non-small cell lung cancer (NSCLC). Bevacizumab was the first angiogenesis inhibitor approved for the treatment of patients with a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Mol Sci
Glavni autori: Manzo, Anna, Montanino, Agnese, Carillio, Guido, Costanzo, Raffaele, Sandomenico, Claudia, Normanno, Nicola, Piccirillo, Maria Carmela, Daniele, Gennaro, Perrone, Francesco, Rocco, Gaetano, Morabito, Alessandro
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2017
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5666703/
https://ncbi.nlm.nih.gov/pubmed/28934120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18102021
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items